VRTX

Name: VRTX FDA catalyst calendar
Creator: Pharmaconomics

VERTEX PHARMS INC

2 catalysts on file

VRTX

VERTEX PHARMS INC

Approval Confirmed

Trikafta

169d ago Mar 27, 2026

openFDA verified 2mo ago

VRTX

Vertex Pharmaceuticals Incorporated

Phase 3 Estimated

CTX001

Beta-Thalassemia

T-minus 267 days Jun 6, 2027

ClinicalTrials.gov verified 2mo ago